{"acquisitions":[],"changes":[{"companyHref":"/c/diagonaltx-com","date":"2026-10-03","documentUrl":"https://atlasventure.com/portfolio/","domain":"diagonaltx.com","fact":"provenance:existence","name":"Diagonal Therapeutics","new":{"publisher":"Atlas Venture","status":"sourced","url":"https://atlasventure.com/portfolio/"},"old":{"publisher":"diagonaltx.com","status":"self-reported","url":"https://diagonaltx.com"},"publisher":"Atlas Venture","reason":null,"retrievedAt":"2026-10-03","slug":"diagonaltx-com","status":"sourced","url":"https://whoraisedwhat.com/c/diagonaltx-com"},{"companyHref":"/c/diagonaltx-com","date":"2026-09-30","documentUrl":"https://atlasventure.com/portfolio/","domain":"diagonaltx.com","fact":"provenance:investor:atlas-venture","name":"Diagonal Therapeutics","new":{"publisher":"Atlas Venture","status":"sourced","url":"https://atlasventure.com/portfolio/"},"old":{"publisher":null,"status":"unknown","url":null},"publisher":"Atlas Venture","reason":null,"retrievedAt":"2026-09-30","slug":"diagonaltx-com","status":"sourced","url":"https://whoraisedwhat.com/c/diagonaltx-com"}],"country":"US","description":"Diagonal Therapeutics develops clustering antibodies that bind multiple receptors at once to regulate signaling and modify disease at its root. It targets genetic and chronic conditions like hereditary hemorrhagic telangiectasia and pulmonary hypertension. Its edge is an engine screening billions of antibody combinations to design them.","domain":"diagonaltx.com","employees":null,"founded":2022,"fundingTotalQuarantined":false,"githubOrg":"diagonaltx","githubStars":null,"industry":"unknown","industrySources":[],"investors":["atlas-venture"],"lat":52.197585,"lng":0.139154,"location":"Cambridge","multiples":[],"name":"Diagonal Therapeutics","nameSource":{"publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},"people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":125000000,"connectionsAmong":[],"currency":"USD","date":"2026-01-08","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"diagonaltx-com-2026-01-08-series-b","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-13","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"diagonaltx-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-13","status":"attributed","url":null},{"fact":"existence","publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},{"fact":"description","publisher":"diagonaltx.com","retrievedAt":"2026-10-03","status":"self-reported","url":"https://diagonaltx.com"},{"fact":"investor:atlas-venture","publisher":"Atlas Venture","retrievedAt":"2026-09-30","status":"sourced","url":"https://atlasventure.com/portfolio/"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[{"id":"investor:{\"actorKind\": \"investor\", \"name\": \"Atlas Venture\", \"role\": \"portfolio\", \"slug\": \"atlas-venture\", \"sources\": [{\"publisher\": \"Atlas Venture\", \"retrievedAt\": \"2026-09-30\", \"status\": \"sourced\", \"url\": \"https://atlasventure.com/portfolio/\"}]}","kind":"investor","sources":[{"publisher":"Atlas Venture","retrievedAt":"2026-09-30","status":"sourced","url":"https://atlasventure.com/portfolio/"}],"text":"Diagonal Therapeutics was listed in Atlas Venture's portfolio, recorded 2026-09-30."}],"generatedAt":"2026-11-09","investors":[{"actorKind":"investor","name":"Atlas Venture","role":"portfolio","slug":"atlas-venture","sources":[{"publisher":"Atlas Venture","retrievedAt":"2026-09-30","status":"sourced","url":"https://atlasventure.com/portfolio/"}]}],"state":"insufficient-evidence","tldr":[]},"techStack":["adobe fonts","hsts","netlify","next.js","react","typekit","webpack"],"totalRaisedUsd":253000000,"traction":[],"updatedAt":"2026-10-03","valuations":[]}